11.25.13
The FDA has expanded the approved use of the cancer drug Nexavar to include late-stage differentiated thyroid cancer, the most common type of thyroid cancer.
Nexavar is made by Bayer AG and Onyx Pharmaceuticals and is also approved to treat advanced kidney cancer and liver cancer. Onyx was acquired by Amgen earlier this year.
Nexavar is made by Bayer AG and Onyx Pharmaceuticals and is also approved to treat advanced kidney cancer and liver cancer. Onyx was acquired by Amgen earlier this year.